{"Clinical Trial ID": "NCT02995980", "Intervention": ["INTERVENTION 1:", "Contrast Improved Mammography", "\u00b7 Improved contrast spectral mammography for the detection of breast cancer.", "DECE mammography: contrasting mammography", "INTERVENTION 2:", "Standard digital mammography", "In-field digital mammography for breast cancer detection", "Digital mammography: routine digital mammography"], "Eligibility": ["Incorporation criteria:", "Signed informed consent", "At least 19 years of age", "Glamerular filtration rate > 60", "- Heterogenic or extremely dense breasts (BI-RADS category c or d).", "- Exclusion criteria:", "\u2022 History of allergy to iodized contrast", "Pregnant or lactating according to standard practice", "Personal history of breast cancer", "Previous history of breast excision biopsy (Patients with a history of needle heart biopsy will not be excluded)", "\u2022 Previous breast reduction mastoplasty surgery history", "\u2022 Previous history of breast augmentation surgery", "A mental condition that renders the subject unable to understand the nature, scope and possible consequences of the study."], "Results": ["Performance measures:", "Percentage accuracy of mammography contrast", "The main evaluation criterion for this study is to determine the accuracy of EC mammography with respect to digital field mammography (FFDM) in patients with increased breast density (BCI-RADS) category c or d).", "Time limit: 1 year", "Results 1:", "Title of the arm/group: Enhanced contrasting mammography", "Description of the arm/group: Enhanced contrast spectral mammography for the detection of breast cancer.", "DECE mammography: contrasting mammography", "Total number of participants analysed: 114", "Type of measurement: Number", "Unit of measurement: precision percentage 100 (29 to 100)", "Results 2:", "Title of the arm/group: Standard digital mammography", "Description of the arm/group: Digital mammography in the field for the detection of breast cancer", "Digital mammography: routine digital mammography", "Total number of participants analysed: 114", "Type of measurement: Number", "Unit of measurement: precision percentage 67 (9 to 99)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/128 (0.00 per cent)", "Adverse Events 2:", "- Yeah, that's right."]}